Tissue and BAL Based Biomarkers in Asthma

Immunology and Allergy Clinics of North America

Volumn 27, Issue 4, 2007, Pages 623-632

  Zhang, June Y ^a   Wenzel, Sally E ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AIRWAY; ASTHMA; BRONCHOSCOPY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG LAVAGE; LUNG PARENCHYMA; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; SPUTUM ANALYSIS;

ASTHMA; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILIA; HUMANS; INTERLEUKIN-5; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 9;

EID: 35748971803     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.09.003     Document Type: Review

References (66)

1. Bousquet J., Chanez P., Lacoste J.Y., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 15 (1990) 1033-1039
2. Wenzel S.E., Schwartz L.B., Langmack E.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 3 (1999) 1001-1008
3. Miranda C., Busacker A., Balzar S., et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 113 1 (2004) 101-108
4. Haldar P., and Pavord I.D. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 119 5 (2007) 1043-1052
5. Lemière C., Ernst P., Olivenstein R., et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 118 5 (2006) 1033-1039
6. Green R.H., Brightling C.E., McKenna S., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 9347 (2002) 1715-1721
7. Jayaram L., Pizzichini M.M., Cook R.J., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 3 (2006) 483-494
8. Wenzel S.E. Severe asthma in adults. Am J Respir Crit Care Med 172 2 (2005) 149-160
9. Silkoff P.E., Lent A.M., Busacker A.A., et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 116 6 (2005) 1249-1255
10. Menzies-Gow A., Flood-Page P., Sehmi R., et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111 4 (2003) 714-719
11. Yamaguchi Y., Suda T., Suda J., et al. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167 1 (1988) 43-56
12. Palframan R.T., Collins P.D., Severs N.J., et al. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 188 9 (1998) 1621-1632
13. Tavernier J., Van de Heyen J., Verhee A., et al. Interleukin-5 regulates the isoform expression of its won receptor alpha-subunit. Blood 95 5 (2000) 1600-1607
14. Sehmi R., Wood L.J., Watson R., et al. Allergen-induced increases in IL-5 receptor α-subunit expression on bone marrow derived CD34+ cells from asthmatic subjects: a novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 100 10 (1997) 2466-2475
15. Menzies-Gow A.N., Flood-Page P.T., Robinson D.S., et al. Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatics and non-asthmatic volunteers. Clin Exp Allergy 37 7 (2007) 1023-1032
16. Kelly E.A., Rodriguez R.R., Busse W.W., et al. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med 156 5 (1997) 1421-1428
17. Liu L.Y., Sedgwick J.B., Bates M.E., et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 169 11 (2002) 6452-6458
18. Hamid Q., Azzawi M., Ying S., et al. Expression of mRNA for IL-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87 5 (1991) 1541-1546
19. Humbert M., Corrigan C.J., Kimmitt P., et al. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 156 3 Pt 1 (1997) 704-708
20. Leckie M.J., ten Brinke A., Khan J., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 9248 (2000) 2144-2148
21. Stein M.L., Collins M.H., Villanueva J.M., et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118 6 (2006) 1312-1319
22. Lamkhioued B., Renzi P.M., Abi-Younes S., et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159 9 (1997) 4593-4601
23. Ying S., Robinson D.S., Meng Q., et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: association with airway hyperresponsiveness and predominant co-localization of eotaxin in mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 27 12 (1997) 3507-3516
24. Lamkhioued B., Abddelilah S.G., Hamid Q., et al. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 170 1 (2003) 537-547
25. Li L., Xia Y., Nguyen A., et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162 5 (1999) 2477-2487
26. Adelroth E. How to measure airway inflammation: bronchoalveolar lavage and airway biopsies. Can Respir J 5 Suppl A (1998) 18A-21A
27. Batra V., Musani A.I., Hastie A.T., et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 34 3 (2004) 437-444
28. Wenzel S.E., Larsen G.L., Johnston K., et al. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 142 1 (1990) 112-119
29. Taylor G.W., Taylor I., Black P., et al. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1 8638 (1989) 584-588
30. Pavord I.D., Ward R., Woltmann G., et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 160 6 (1999) 1905-1909
31. Montuschi P., and Barnes P.J. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 109 4 (2002) 615-620
32. 1 receptor. Nature 399 6738 (1999) 789-793
33. Pizzichini E., Leff J.A., Reiss T.F., et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 14 1 (1999) 12-18
34. Calhoun W.J., Lavins B.J., Minkwitz M.C., et al. Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge. Am J Respir Crit Care Med 157 5 Pt 1 (1998) 1381-1389
35. Stelmach I., Jerzynska J., and Kunan P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 109 2 (2002) 257-263
36. Chu H.W., Balzar S., Westcott J.Y., et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 32 11 (2002) 1558-1565
37. Nassar G.M., Morrow J.D., Roberts II L.J., et al. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 269 44 (1994) 27631-27634
38. Profita M., Vignola A.M., Sala A., et al. Interleukin-4 enhances 15-lipoxygenase activity and incorporation of 15(S)-HETE into cellular phospholipids in cultured pulmonary epithelial cells. Am J Respir Cell Mol Biol 20 1 (1999) 61-68
39. Douwes J., Gibson P., Pekkanen J., et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57 7 (2002) 643-648
40. Wenzel S.E., Szefler S.J., Leung D.Y., et al. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156 3 Pt 1 (1997) 737-743
41. Jatakanon A., Uasuf C., Maziak W., et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160 5 Pt 1 (1999) 1532-1539
42. Wenzel S.E., Trudeau J.B., Kaminsky D.A., et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 152 3 (1995) 897-905
43. Krawiec M.E., Westcott J.Y., Chu H.W., et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 163 6 (2001) 1338-1343
44. Hollander C., Sitkauskiene B., Sakalauskas R., et al. Serum and bronchial lavage fluid concentrations of IL-8 SLPI, sCD14, and sICAM-1 in patients with COPD and asthma. Respir Med 101 9 (2007) 1947-1953
45. Kim C.K., Kim S.W., Kim Y.K., et al. Bronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis. Clin Exp Allergy 35 5 (2005) 591-597
46. Wenzel S.E., Balzar S., Cundall M., et al. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 111 6 (2003) 1345-1352
47. Ohbayashi H., and Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy 4 2 (2005) 177-181
48. Mautino G., Oliver N., Chanez P., et al. Increased release of matrix matelloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 17 5 (1997) 583-591
49. Ko F.W., Diba C., Roth M., et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 127 6 (2005) 1919-1927
50. Tang L.F., Du L.Z., Chen Z.M., et al. Levels of matrix metalloproteinase-9 and its inhibitor in bronchoalveolar lavage cells of asthmatic children. Fetal Pediatr Pathol 25 1 (2006) 1-7
51. Cundall M., Sun Y., Miranda C., et al. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 112 6 (2003) 1064-1071
52. Hoshino M., Nakamura Y., Sim J., et al. Bronchial subepithelial fibrosis and expression of matrix mattaloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 102 5 (1998) 783-788
53. Benayoun L., Druilhe A., Dombret M.C., et al. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167 10 (2003) 1360-1368
54. Slats A.M., Janssen K., van Schadewijk A., et al. Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176 2 (2007) 121-128
55. Bradding P., Wall A.F., and Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117 6 (2006) 1277-1284
56. Balzar S., Chu H.W., and Wenzel S.E. Mast cell phenotypes in large airway smooth muscle and submucosa of normal subjects and asthmatics do not correlate with lung function. American Thoracic Society (2005) [poster L46]
57. Chetta A., Foresi A., Del Donno M., et al. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111 4 (1997) 852-857
58. Chu H.W., Halliday J.L., Martin R.J., et al. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 158 6 (1998) 1936-1944
59. Bourdin A., Neveu D., Vachier I., et al. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 119 6 (2007) 1367-1374
60. Kariyawasam H.H., Aizen M., Barkans J., et al. Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med 175 9 (2007) 896-904
61. Minshall E.M., Leung D.Y., Martin R.J., et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17 3 (1997) 326-333
62. Balzar S., Chu H., Silkoff P., et al. Increased TGF-beta2 in severe asthma with eosinophilia. J Allergy Clin Immunol 115 1 (2005) 110-117
63. Chu H.W., Trudeau J.B., Balzar S., et al. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 106 6 (2000) 1115-1123
64. Flood-Page P., Menzies-Gow A., Phipps S., et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112 7 (2003) 1029-1036
65. Balzar S., Chu H.W., Strand M., et al. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med 171 5 (2005) 431-439
66. Zanini A., Chetta A., Saetta M., et al. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol 120 2 (2007) 329-333